Correlation Between Youngsin Metal and Prestige Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Youngsin Metal and Prestige Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Youngsin Metal and Prestige Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Youngsin Metal Industrial and Prestige Biologics Co, you can compare the effects of market volatilities on Youngsin Metal and Prestige Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Youngsin Metal with a short position of Prestige Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Youngsin Metal and Prestige Biologics.

Diversification Opportunities for Youngsin Metal and Prestige Biologics

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Youngsin and Prestige is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Youngsin Metal Industrial and Prestige Biologics Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prestige Biologics and Youngsin Metal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Youngsin Metal Industrial are associated (or correlated) with Prestige Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prestige Biologics has no effect on the direction of Youngsin Metal i.e., Youngsin Metal and Prestige Biologics go up and down completely randomly.

Pair Corralation between Youngsin Metal and Prestige Biologics

Assuming the 90 days trading horizon Youngsin Metal Industrial is expected to under-perform the Prestige Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Youngsin Metal Industrial is 2.01 times less risky than Prestige Biologics. The stock trades about -0.05 of its potential returns per unit of risk. The Prestige Biologics Co is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  468,000  in Prestige Biologics Co on September 5, 2024 and sell it today you would earn a total of  81,000  from holding Prestige Biologics Co or generate 17.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Youngsin Metal Industrial  vs.  Prestige Biologics Co

 Performance 
       Timeline  
Youngsin Metal Industrial 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Youngsin Metal Industrial has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Prestige Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prestige Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Prestige Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Youngsin Metal and Prestige Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Youngsin Metal and Prestige Biologics

The main advantage of trading using opposite Youngsin Metal and Prestige Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Youngsin Metal position performs unexpectedly, Prestige Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Biologics will offset losses from the drop in Prestige Biologics' long position.
The idea behind Youngsin Metal Industrial and Prestige Biologics Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments